Latest International Expansion News

Way2VAT Ltd has secured a strategic acquisition of UK-based RBC VAT Limited alongside a $4.1 million placement, accelerating its expansion in VAT compliance and consultancy services.

Wellnex Life has secured a significant opening order from global partner Haleon for its Liquid Paracetamol and Ibuprofen softgel products in the UAE, marking the fourth national market in Haleon's distribution network. This milestone supports Wellnex's revenue forecasts for 2025 and underscores its strategic focus on innovative healthcare products.

PainChek’s UK pilot reveals significant clinical improvements and economic benefits, positioning the digital pain assessment app for broader adoption in Scotland and beyond.

Jatcorp has officially appointed Dr Xinpeng (Sean) Li as its CEO, locking in a three-year contract that underscores a strategic focus on sustainable growth and innovation.

Bioxyne Limited has secured import permits and purchase orders worth A$5.1 million for medical cannabis in Germany, signaling strong early traction in a key European market.

Red Sky Energy has formalized its 35% interest in Angola’s Block 6/24 following parliamentary ratification of the Risk Service Contract, unlocking access to significant oil resources and advancing its international growth strategy.

KMD Brands has launched a comprehensive 'Next Level' turnaround strategy targeting $25 million in cost savings alongside $15 million in growth investments, aiming to restore profitability and accelerate brand-led expansion.

Biome Australia has partnered with Green Cross Health to launch its Activated Probiotics across New Zealand’s largest pharmacy network, marking a pivotal step in its international growth strategy.

Collins Foods has reported a robust 6.7% increase in total sales for the first 18 weeks of FY26, driven by strong same-store sales growth in Australia, the Netherlands, and Germany. The company reaffirms its optimistic profit guidance amid ongoing expansion and operational improvements.

Halo Technologies Holdings Ltd has announced a renounceable pro rata rights issue aiming to raise up to $11 million at $0.024 per share, partially underwritten by Lodge Corporate Pty Ltd. The capital raise will support the company’s UK market entry, local growth, and ongoing software development.

My Rewards International Limited reports a 47% revenue drop but narrows losses by 45%, fueled by strategic acquisition and tech innovation. The company advances ASX reinstatement with a capital raise and debt conversion plan.

Bioxyne Limited projects FY2026 revenue between $65 million and $75 million, driven by expansion in Australian medical cannabis and a landmark $5.8 million contract in Germany.